Brown Brothers Harriman & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.2K | Buy |
732
+292
| +66% | +$8.06K | ﹤0.01% | 1091 |
|
2025
Q1 | $12.5K | Sell |
440
-69
| -14% | -$1.96K | ﹤0.01% | 1032 |
|
2024
Q4 | $21.2K | Sell |
509
-23
| -4% | -$956 | ﹤0.01% | 1012 |
|
2024
Q3 | $35.6K | Sell |
532
-124
| -19% | -$8.29K | ﹤0.01% | 856 |
|
2024
Q2 | $77.9K | Sell |
656
-52
| -7% | -$6.18K | ﹤0.01% | 695 |
|
2024
Q1 | $75.4K | Buy |
708
+199
| +39% | +$21.2K | ﹤0.01% | 692 |
|
2023
Q4 | $50.6K | Sell |
509
-410
| -45% | -$40.8K | ﹤0.01% | 730 |
|
2023
Q3 | $94.9K | Sell |
919
-200
| -18% | -$20.7K | ﹤0.01% | 606 |
|
2023
Q2 | $136K | Sell |
1,119
-506
| -31% | -$61.5K | ﹤0.01% | 540 |
|
2023
Q1 | $250K | Sell |
1,625
-92
| -5% | -$14.1K | ﹤0.01% | 447 |
|
2022
Q4 | $308K | Sell |
1,717
-94
| -5% | -$16.9K | ﹤0.01% | 385 |
|
2022
Q3 | $214K | Buy |
1,811
+39
| +2% | +$4.61K | ﹤0.01% | 446 |
|
2022
Q2 | $253K | Buy |
1,772
+65
| +4% | +$9.28K | ﹤0.01% | 424 |
|
2022
Q1 | $294K | Hold |
1,707
| – | – | ﹤0.01% | 429 |
|
2021
Q4 | $434 | Hold |
1,707
| – | – | ﹤0.01% | 356 |
|
2021
Q3 | $657 | Hold |
1,707
| – | – | ﹤0.01% | 286 |
|
2021
Q2 | $401 | Hold |
1,707
| – | – | ﹤0.01% | 343 |
|
2021
Q1 | $224 | Buy |
1,707
+1,307
| +327% | +$172 | ﹤0.01% | 394 |
|
2020
Q4 | $42K | Hold |
400
| – | – | ﹤0.01% | 690 |
|
2020
Q3 | $28K | Sell |
400
-1,074
| -73% | -$75.2K | ﹤0.01% | 646 |
|
2020
Q2 | $95K | Buy |
1,474
+1,074
| +269% | +$69.2K | ﹤0.01% | 491 |
|
2020
Q1 | $12K | Buy |
+400
| New | +$12K | ﹤0.01% | 683 |
|